Prostamax
Prostamax is a bioregulatory peptide discussed for prostate-tissue support and local inflammatory balance, with the source protocol using a daily intramuscular route rather than the more common subcutaneous pattern.
Overview
Prostamax is presented in the source as a prostate-focused bioregulatory peptide aimed at tissue support and inflammatory-balance signaling. It is part of the broader short-peptide bioregulator family rather than a classic receptor agonist or hormone analog.
This page is an edge case for the library because the source protocol uses intramuscular injection rather than subcutaneous injection. The content below preserves that route instead of forcing it into the wrong template.
At a Glance
Protocol
Suggested daily intramuscular titration approach starting lower and increasing over the first month.
Inject once daily intramuscularly using a very small volume. The source frames this as a prostate-support bioregulator rather than a hormone replacement or anti-androgen therapy, and the evidence base remains limited.
Dose progression
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
How Prostamax works.
Prostamax is presented as a prostate-focused tissue bioregulator with proposed anti-inflammatory and local-support effects rather than a systemic endocrine therapy. The source places it alongside other organ-specific short peptides.
The evidence base remains limited and should be treated as exploratory. This is best viewed as a peptide-library educational summary rather than a clinically established prostate protocol.
Effects
Observations from clinical or preclinical literature.
Caution
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
CoFactors
Life Factors
Complementary strategies for best outcomes.
Metrics
Day-to-day metrics worth tracking through the protocol.
- Urinary symptoms and comfort - useful for symptom-context tracking
- Pelvic discomfort or inflammatory symptoms - broader response context
- Injection-site soreness - especially relevant for intramuscular use
Labs
Baseline and periodic bloodwork to monitor systemic health during the protocol.
Supplies Calculator
Estimates assume the schedule defined for this peptide.
Dose Calculator
Dose Calculator
Preparation
Careful technique preserves potency. Solution should be clear — do not shake.
- Allow vial to reach room temperature for 15–20 minutes before reconstitution.
- Draw the chosen bacteriostatic water volume with a sterile syringe.
- Inject slowly down vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
- Use within 30 days; discard any unused solution after 30 days.
Technique
General subcutaneous guidance from clinical best-practice resources.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Storage
Notes
Notes
References
- Short-peptide bioregulator literatureBackground literature relevant to organ-specific bioregulator peptides.https://pubmed.ncbi.nlm.nih.gov/25482216/
- CDCGeneral injection safety and route guidance.https://www.cdc.gov/injection-safety/hcp/clinical-safety/index.html